Skip to main content

KNSA

Stock
Health Care
Biotechnology

Performance overview

KNSA Price
Price Chart

Forward-looking statistics

Beta
0.82
Risk
44.23%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

kiniksa pharmaceuticals combines an experienced management team and significant committed capital in order to acquire, develop, and commercialize therapeutics treating devastating diseases with high unmet needs.

Company info

SectorHealth Care
IndustryBiotechnology
Employees260
Market cap$1.4B

Fundamentals

Enterprise value$1.8B
Revenue$481.2M
Revenue per employee—
Profit margin-3.52%
Debt to equity2.17

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.24
Dividend per share—
Revenue per share$6.69
Avg trading volume (30 day)$27M
Avg trading volume (10 day)$42M
Put-call ratio—

Macro factor sensitivity

Growth+1.1
Credit+3.3
Liquidity-0.1
Inflation-1.0
Commodities-0.9
Interest Rates-2.6

Valuation

Dividend yield0.00%
PEG Ratio50.69
Price to sales4.23
P/E Ratio50.69
Enterprise Value to Revenue3.66
Price to book4.44

Upcoming events

Next earnings dayApril 23, 2024
Next dividend day—
Ex. dividend day—

News

5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position EXEL, VRNA, ALKS, KNSA and IMCR well in this volatile sector.

Zacks Investment Research (July 2, 2025)
Kiniksa Pharmaceuticals, Ltd. (KNSA) Tops Q1 Earnings and Revenue Estimates

Kiniksa Pharmaceuticals, Ltd. (KNSA) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.02 per share.

Zacks Investment Research (April 29, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free